Inhaled powder could offer rapid migraine relief without needles
NCT ID NCT07646613
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an investigational inhaled medication called ASY202 (dihydroergotamine dry powder) for treating migraine attacks in adults. Participants use a handheld inhaler to take the drug or a placebo during separate migraine episodes, and neither they nor the study team know which is which. The goal is to see if ASY202 can stop headache pain and bothersome symptoms like light sensitivity or nausea within two hours. The trial involves about 108 people and lasts around 16 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dihydroergotamine (DHE) inhaled dry powder
What this could lead to
If successful, this could provide a fast-acting, non-injectable option for treating migraine attacks at home.
What could go wrong
This is an early-phase trial with only 108 participants, so results may not apply to everyone. Inhaled DHE may cause side effects like throat irritation or nausea.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Highland Research
NOT_YET_RECRUITINGSalt Lake City, Utah, 84124, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
M3 Wake Research - Las Vegas Rainbow
NOT_YET_RECRUITINGLas Vegas, Nevada, 89118, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sunwise Clinical Research, Llc
RECRUITINGWalnut Creek, California, 94596, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••